Mark Stroick
Impact in
- Physiology top 2%
- Alzheimer's disease research and treatments
- Psychiatry and Mental health top 10%
- Dementia and Cognitive Impairment Research
Papers in
-
- Protease and Inhibitor Mechanisms 5
-
- Intracerebral and Subarachnoid Hemorrhage Research 4
- Co-authors
- Michael G. Hennerici (17 shared papers)Klaus C Fassbender (4 shared papers)Thomas Bertsch (4 shared papers)Klaus von Bergmann (4 shared papers)Dieter Lütjohann (3 shared papers)Sandra Kühl (2 shared papers)Christine Bergmann (1 shared paper)Konrad T. Beyreuther (1 shared paper)
- Journals
- Cerebrovascular Diseases (5 papers)Stroke (3 papers)Ultrasound in Medicine & Biology (2 papers)Neurology (1 paper)Thrombosis Research (1 paper)
- Partner nations
- GermanySwedenUnited Kingdom
In The Last Decade
Mark Stroick
20 papers receiving 1.6k citations
Mark Stroick's Hit Papers
Peers
Comparison fields: 5 of 75
- Physiology 766
- Psychiatry and Mental health 193
- Neurology 80
- Cancer Research 83
- Neurology 83
Countries citing papers authored by Mark Stroick
This map shows the geographic impact of Mark Stroick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Stroick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Stroick more than expected).
Fields of papers citing papers by Mark Stroick
This network shows the impact of papers produced by Mark Stroick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Stroick. The network helps show where Mark Stroick may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Stroick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo Hit paper breakdown → | 2001 | 959 |
| 2 | 2004 | 113 | |
| 3 | 2002 | 103 | |
| 4 | 2007 | 102 | |
| 5 | 2009 | 56 | |
| 6 | 2005 | 52 | |
| 7 | 2006 | 42 | |
| 8 | 2008 | 35 | |
| 9 | 2007 | 33 | |
| 10 | 2008 | 30 | |
| 11 | 2006 | 28 | |
| 12 | 2008 | 28 | |
| 13 | 2008 | 25 | |
| 14 | 2006 | 24 | |
| 15 | 2009 | 24 | |
| 16 | 2016 | 10 | |
| 17 | 2002 | 7 | |
| 18 | 2012 | 7 | |
| 19 | 2003 | 4 | |
| 20 | 2006 | 1 |
About Mark Stroick
Mark Stroick is a scholar working on Cancer Research, Neurology, Biomedical Engineering, Epidemiology and Critical Care and Intensive Care Medicine, having authored 20 papers that have together received 1.7k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (5 papers), Ultrasound and Hyperthermia Applications (5 papers), Acute Ischemic Stroke Management (4 papers), Intracerebral and Subarachnoid Hemorrhage Research (4 papers), Cholesterol and Lipid Metabolism (2 papers), Alzheimer's disease research and treatments (2 papers), Dementia and Cognitive Impairment Research (1 paper) and Genetic Associations and Epidemiology (1 paper). The work is most often cited by research in Physiology (766 citations), Psychiatry and Mental health (193 citations), Neurology (80 citations), Cancer Research (83 citations) and Neurology (83 citations). Mark Stroick has collaborated with scholars based in Germany, Sweden and United Kingdom. Frequent co-authors include Michael G. Hennerici, Klaus C Fassbender, Thomas Bertsch, Klaus von Bergmann, Dieter Lütjohann, Sandra Kühl, Christine Bergmann, Konrad T. Beyreuther, Mikael Simons and Heiko Runz. Their work appears in journals such as Cerebrovascular Diseases, Stroke, Ultrasound in Medicine & Biology, Neurology and Thrombosis Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.